|
An overview of the NCI’s Division of Cancer Prevention |
09/28/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
10/05/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
10/12/2022 - 8:00am to 9:00am EDT |
|
Hematology Oncology Grand 2022 |
10/19/2022 - 8:00am to 9:00am EDT |
|
A Multi-Level Model to Address Cervical Cancer Disparities in Appalachia |
10/26/2022 - 8:00am to 9:00am EDT |
|
Optimal Duration of Therapy in Metastatic RCC: Exploring Treatment Free Survival with Immune Checkpoint Inhibitors and Let's talk about the elephant in the room: Hemophagocytic Lymphohistocytosis (HLH) |
11/02/2022 - 8:00am to 9:00am EDT |
|
Complement Activation in HIT |
11/09/2022 - 8:00am to 9:00am EST |
|
Tackling resistance in triple negative breast cancer |
11/16/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
11/23/2022 - 8:00am to 9:00am EST |
|
Hematology Oncology Grand 2022 |
11/30/2022 - 8:00am to 9:00am EST |
